All Stories

  1. Cystadenoma on the edge of the tongue: A case report
  2. Significance of Methyltransferase-like 5 Expression in Oral Squamous Cell Carcinoma
  3. Total m6A RNA levels and VIRMA expression as potential diagnostic and prognostic markers in oral squamous cell carcinoma
  4. MCTP2 is a novel biomarker promoting tumor progression and nodal metastasis in oral squamous cell carcinoma
  5. Role of early growth response-1 as a tumor suppressor in oral squamous cell carcinoma
  6. Spindle cell squamous cell carcinoma of the maxillary sinus as a metachronous head and neck cancer
  7. Solitary circumscribed neuroma of the upper lip: A case report
  8. Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer
  9. Reliability of online dental final exams in the pre and post COVID-19 era: A comparative study
  10. An advanced primary ameloblastoma in the maxilla extending into the maxillary and ethmoid sinus tract: A case report
  11. Periodontitis promotes the expression of gingival transmembrane serine protease 2 (TMPRSS2), a priming protease for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  12. Searching for New Molecular Targets for Oral Squamous Cell Carcinoma with a View to Clinical Implementation of Precision Medicine
  13. In vivo degradation and bone formation behaviors of hydroxyapatite-coated Mg alloys in rat femur
  14. CXCL13 is a differentiation- and hypoxia-induced adipocytokine that exacerbates the inflammatory phenotype of adipocytes through PHLPP1 induction
  15. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction
  16. Low intensity pulsed ultrasound (LIPUS) maintains osteogenic potency by the increased expression and stability of Nanog through spleen tyrosine kinase (Syk) activation
  17. JNK regulates osteoblast differentiation through Id4
  18. Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis
  19. Constitutive activation of p46JNK2 is indispensable for C/EBPδ induction in the initial stage of adipogenic differentiation
  20. Osteopontin inhibits osteoblast responsiveness through the down-regulation of focal adhesion kinase mediated by the induction of low–molecular weight protein tyrosine phosphatase
  21. Lymphomatoid granulomatosis initially presenting as ulcerated subcutaneous and muscle lesions without pulmonary involvement
  22. Clinical and Histologic Aspects of Cervical Cemental Tear as a Risk for Periodontal Diseases
  23. Cemental Tear in an Autotransplanted Tooth That Had Been Functioning for 15 Years
  24. Primary intraosseous squamous cell carcinoma arising from ameloblastoma of the mandible: A case report
  25. SMO Expression in Colorectal Cancer: Associations with Clinical, Pathological, and Molecular Features
  26. A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification
  27. Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer
  28. Expression Profiling of Archival Tumors for Long-term Health Studies
  29. Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress
  30. Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
  31. No Evidence for Interference of H&E Staining in DNA Testing
  32. Postmenopausal Hormone Therapy Is Associated with a Reduced Risk of Colorectal Cancer Lacking CDKN1A Expression
  33. Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
  34. TGFBR2 and BAX Mononucleotide Tract Mutations, Microsatellite Instability, and Prognosis in 1072 Colorectal Cancers
  35. Association of CTNNB1 (β-Catenin) Alterations, Body Mass Index, and Physical Activity With Survival in Patients With Colorectal Cancer
  36. STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
  37. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers
  38. Hypomethylation of the IGF2 DMR in Colorectal Tumors, Detected by Bisulfite Pyrosequencing, Is Associated With Poor Prognosis
  39. Novel Application of Structural Equation Modeling to Correlation Structure Analysis of CpG Island Methylation in Colorectal Cancer
  40. Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers
  41. Cathepsin B Expression and Survival in Colon Cancer: Implications for Molecular Detection of Neoplasia
  42. Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
  43. Ornithine Decarboxylase Antizyme Induces Hypomethylation of Genome DNA and Histone H3 Lysine 9 Dimethylation (H3K9me2) in Human Oral Cancer Cell Line
  44. NRAS Mutations Are Rare in Colorectal Cancer
  45. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer
  46. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors
  47. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review
  48. HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
  49. CDK8 expression in 470 colorectal cancers in relation to β‐catenin activation, other molecular alterations and patient survival
  50. Abstract 4639: Prognostic significance and molecular associations of CDKN2A (p16) promoter methylation and loss of expression in colorectal cancer
  51. PTGER2 Overexpression in Colorectal Cancer Is Associated with Microsatellite Instability, Independent of CpG Island Methylator Phenotype
  52. Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells
  53. Negative Lymph Node Count Is Associated With Survival of Colorectal Cancer Patients, Independent of Tumoral Molecular Alterations and Lymphocytic Reaction
  54. A Prospective Cohort Study Shows Unique Epigenetic, Genetic, and Prognostic Features of Synchronous Colorectal Cancers
  55. Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
  56. Vitamin D Receptor Expression Is Associated with PIK3CA and KRAS Mutations in Colorectal Cancer
  57. Prognostic Significance and Molecular Associations of 18q Loss of Heterozygosity: A Cohort Study of Microsatellite Stable Colorectal Cancers
  58. Interaction of Molecular Markers and Physical Activity on Mortality in Patients with Colon Cancer
  59. p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis
  60. Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer
  61. Characterization of the angiogenic activity of zebrafish ribonucleases
  62. A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases
  63. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
  64. A Cohort Study of STMN1 Expression in Colorectal Cancer: Body Mass Index and Prognosis
  65. A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival
  66. DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
  67. Aurora-A Expression Is Independently Associated with Chromosomal Instability in Colorectal Cancer
  68. Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis
  69. PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
  70. JC Virus T-Antigen in Colorectal Cancer Is Associated with p53 Expression and Chromosomal Instability, Independent of CpG Island Methylator Phenotype
  71. Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
  72. Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth
  73. Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample
  74. Ornithine Decarboxylase Antizyme Upregulates DNA-Dependent Protein Kinase and Enhances the Nonhomologous End-Joining Repair of DNA Double-Strand Breaks in Human Oral Cancer Cells
  75. Connexin 43 transfection in basaloid squamous cell carcinoma cells
  76. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue
  77. Schwannoma of the Mandible
  78. Nuclear Accumulation of Basic Fibroblast Growth Factor as a Predictor for the Recurrence of Pituitary Adenomas
  79. Prevalence of Epstein-Barr virus in oral squamous cell carcinoma